Status:
RECRUITING
Therapeutic Omegas for Triglyceride Suppression
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
University of Oklahoma
Conditions:
Pregnancy
Eligibility:
All Genders
Up to 39 years
Phase:
NA
Brief Summary
This study plans to learn more about how an omega-3 fatty acid supplement effects triglyceride levels in pregnancy. Triglycerides are a type of fat found in your blood. Your body converts extra calori...
Eligibility Criteria
Inclusion
- Pregnant women between the ages of 21-39 yrs
- Pre-pregnancy BMI 28-39
- Fasting Triglyceride ≥120 mg/dL measured by 15 wks
Exclusion
- Pre-gestational diabetes or prediabetes
- History of gestational diabetes,
- History of pre-eclampsia, spontaneous pre-term delivery, or gestational hypertension \<34wks
- Tobacco or illicit substance use
- Chronic steroid use
Key Trial Info
Start Date :
November 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04349475
Start Date
November 29 2021
End Date
December 31 2025
Last Update
October 4 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado/Anschutz Medical Campus
Aurora, Colorado, United States, 80045
2
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States, 73104